The modulation of the β‐catenin/c‐Myc axis was further investigated in a spf‐ash mice, a genetic model of OTC (ornithine‐transcarbamylase enzyme) deficiency and an in vivo model of hyperammonemia. This evidence concerns the gene MYC and Hyperammonemia.